WALTHAM, Mass, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Zenas BioPharma, Inc. (“Zenas” or the “Company”) (Nasdaq: ZBIO), a clinical-stage global biopharmaceutical company committed to being a leader in...
RIYADH, Saudi Arabia, Nov. 07, 2024 (GLOBE NEWSWIRE) -- 20 agreements worth more than 1.35bn Saudi Riyals were signed on the second day of Biban24 forum. In line with Vision 2030, these partnerships...
